Executive Team - David Karp

Chief Financial Officer

As Chief Financial Officer for CounterPath, David Karp manages accounting, finance, planning and investor relations, allowing the company to better execute on its strategic and financial goals.

David was previously Chief Financial Officer of Chemokine Therapeutics Corp., a Vancouver based, publicly traded biotechnology company where he was instrumental in the company's successful initial public offering and follow-on financing. In addition to raising over $25 million, David was responsible for treasury and U.S. GAAP reporting, as well as the implementation of internal controls. Prior to this position, David was Chief Financial Officer of Neuro Discovery Inc., a Vancouver-based, publicly traded investment company focused on biotechnology investing.

David brings more than fifteen years of corporate finance and operating experience, including raising hundreds of millions of dollars through equity financings and managing a number of merger and acquisition assignments, while Vice-President, Investment Banking, for BMO Nesbitt Burns, one of North America's leading full-service investment firms, in Vancouver. David holds a Bachelor of Science degree in Mechanical Engineering from the University of Waterloo in Ontario, an MBA from the Ivey School of business in London, Ontario, and is a CFA charterholder.